Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Hypertens. 2016 Oct;34(10):2008–2025. doi: 10.1097/HJH.0000000000001029

FIGURE 5.

FIGURE 5

Kidney epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids ratio (a), kidney angiotensin II levels (b), kidney angiotensin-converting enzyme activity (c), the ratio of kidney angiotensin II to angiotensin I levels (d), in indole-3-carbinol induced and noninduced Cyp1a1-Ren-2 transgenic rats. Effects of epoxyeicosatrienoic acid analog and angiotensin-converting enzyme inhibition treatment. *P < 0.05 versus noninduced rat @P < 0.05 versus untreated indole-3-carbinol induced rats.